GW Pharma's cannabis drug helps in resistant epilepsy

LONDON, June 17 Tue Jun 17, 2014 7:09am EDT

LONDON, June 17 (Reuters) - GW Pharmaceuticals, which is developing a range of drugs based on cannabis, said on Tuesday its experimental product Epidiolex had produced promising results in children and young adults with treatment-resistant epilepsy.

The findings follow an assessment of 27 patients treated with the drug for 12 weeks.

(Reporting by Ben Hirschler; editing by Kate Kelland)